Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JBVTF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2021147993A1 ADC-3
|
|||||
| Synonyms |
WO2021147993A1 ADC 3
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Gastric cancer [ICD11:2B72]
Investigative
Pancreatic cancer [ICD11:2C10]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.14
|
|||||
| Structure |
|
|||||
| Antibody Name |
PD3
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
WO2021147993A1 ADC-3 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.